No, President Trump’s Regeneron Therapy Did Not Contain Human Embryonic Stem Cells

Regeneron America Charlotte Lozier Institute Coronavirus LifeNews Medical President Trump Press ProLife Social Media Twitter

No, President Trump’s Regeneron Therapy Did Not Contain Human Embryonic Stem Cells

Uninformed commentary has emerged this morning stating that President Trump has received a medication created with the use of human embryonic stem cells. CLI has reviewed the published information and our conclusion is straightforward: The president was not given any medicines to treat COVID-19 that involved the destruction of human life.

CLI Responds to Misinformation Regarding President Trump’s COVID-19 Treatment

A statement from David Prentice, Ph.D., and Tara Sander Lee, Ph.D., of the Charlotte Lozier Institute: “Uninformed commentary has emerged this morning stating that President Trump has received a medication created with the use of human embryonic stem cells.

Regeneron’s REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 Patients | Regeneron Pharmaceuticals Inc.

TARRYTOWN, N.Y. , Sept. 29, 2020 /PRNewswire/ — Greatest improvements in patients who had not mounted their own effective immune response prior to treatment Plan rapidly to discuss results with regulatory authorities Regeneron to host investor and media webcast to discuss results at 4:30 pm ET